Trasturel Reliance Trastuzumab Injection

Trasturel Reliance Trastuzumab Injection About

Trasturel Injection is a high-quality Trastuzumab formulation manufactured by Reliance Life Sciences, widely used in the treatment of HER2-positive cancers. It is a monoclonal antibody that specifically targets the HER2 receptor, helping to inhibit the growth of cancer cells and improve clinical outcomes in eligible patients.

This injection is commonly prescribed for HER2-positive breast cancer and HER2-positive gastric or gastroesophageal junction cancers, either as monotherapy or in combination with chemotherapy, as per the treating oncologists protocol.

Trasturel meets stringent quality and safety standards, ensuring reliable efficacy and patient safety. It is supplied in lyophilized form for intravenous administration and should be used strictly under medical supervision.

• HER2-positive early and metastatic breast cancer

• HER2-positive metastatic gastric or gastroesophageal junction adenocarcinoma

• Store at 2C to 8C

• Do not freeze

• Protect from light